India: Licensing & Syndication

The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".

Digital piracy encompasses the unauthorised copying, distribution, and consumption of copyrighted digital content. It manifests through various channels, from illegal downloads and streams to sophisticated distribution networks that operate across borders...

The Hon'ble Delhi High Court granted superlative injunction which has been referred to as an extended version of dynamic+ injunction while deciding an application under Order XXXIX Rule 1 and 2...

Copyright law exists as a cornerstone of intellectual property rights, seeking to safeguard the original expression of ideas across various domains of creativity.

Introduction: The Dual Approach of Copyright Laws The Copyright laws take a dual approach in balancing the equilibrium of interest between creators and public interest, considering the user needs of copyrighted material while enhancing the reconciliation between two parallel goals.

Design protection remains fundamental to protect the quickly evolving creative field whose components include product manufacturing together with graphic design work and fashion creations.

The 21st century has seen a rapid surge in technological innovation, from minor tweaks to revolutionary breakthroughs.

HTF Market Intelligence Consulting Pvt. Ltd. released a detailed study on the Global Chemical Licensing Market, projecting its valuation to rise from USD 11 billion in 2025 to USD 20 billion by 2032...

In recent years, the Indian Patent Office has adopted a stricter interpretation of Section 3(b) of the Patents Act, 1970, leading to increased rejections of patent applications.

The Delhi High Court has recently delivered two judgments underscoring how the procedural failures by the patent and trademark offices can unjustly prejudice rights.